1. Home
  2. INO
  3. INO News

Latest Inovio Pharmaceuticals Inc. (INO) News on October 8, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Will Have To Spend Its Cash Wisely
INO

Simply Wall St.

4 months ago

Inovio Pharmaceuticals (NASDAQ:INO) Will Have To Spend Its Cash Wisely

INO

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Inovio Pharmaceuticals Inc Earnings Call

INO

MT Newswires

5 months ago

Oppenheimer Adjusts Inovio Pharmaceuticals Price Target to $13 From $15, Maintains Outperform Rating

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ...
INO

GuruFocus.com

5 months ago

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ...

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates
INO

Zacks

5 months ago

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

INO

Associated Press Finance

5 months ago

Inovio: Q1 Earnings Snapshot

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
INO

PR Newswire

5 months ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

INOVIO to Present at Upcoming Scientific and Investor Conferences
INO

PR Newswire

5 months ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
INO

PR Newswire

5 months ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Bet on These 5 Top-Ranked Stocks With Rising P/E
INO

Zacks

6 months ago

Bet on These 5 Top-Ranked Stocks With Rising P/E

Inovio (INO) Upgraded to Buy: Here's What You Should Know
INO

Zacks

6 months ago

Inovio (INO) Upgraded to Buy: Here's What You Should Know

INOVIO to Present at Upcoming Scientific Conferences
INO

PR Newswire

6 months ago

INOVIO to Present at Upcoming Scientific Conferences

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)
INO

Zacks

6 months ago

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)

INO

MT Newswires

7 months ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
INO

GuruFocus.com

7 months ago

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript
INO

Motley Fool

7 months ago

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
INO

PR Newswire

7 months ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

INO

MT Newswires

7 months ago

Sector Update: Health Care Stocks Higher Premarket Friday

INO

MT Newswires

7 months ago

Inovio Pharmaceuticals Reports Interim Trial Results of DNA-Encoded Monoclonal Antibodies for COVID-19

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
INO

PR Newswire

7 months ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
INO

PR Newswire

7 months ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher
INO

Zacks

8 months ago

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
INO

PR Newswire

8 months ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
INO

PR Newswire

8 months ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
INO

PR Newswire

8 months ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
INO

PR Newswire

9 months ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

INO

MT Newswires

10 months ago

Top Midday Decliners

INO

MT Newswires

10 months ago

Inovio Prices $30 Million Public Offering of Shares, Accompanying Warrants

INOVIO Announces Pricing of $30 Million Public Offering
INO

PR Newswire

10 months ago

INOVIO Announces Pricing of $30 Million Public Offering

INOVIO Announces Proposed Public Offering
INO

PR Newswire

10 months ago

INOVIO Announces Proposed Public Offering

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
INO

PR Newswire

10 months ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

10 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

INO

MT Newswires

a year ago

Oppenheimer Adjusts Inovio Pharmaceuticals Price Target to $15 From $33, Maintains Outperform Rating

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)
INO

Simply Wall St.

a year ago

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)

INO

MT Newswires

a year ago

RBC Lowers Price Target on Inovio Pharmaceuticals to $6 From $7, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...
INO

GuruFocus.com

a year ago

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...

Where are they now? 4 biotechs that soared then crashed during the pandemic
INO

Pharma Voice

a year ago

Where are they now? 4 biotechs that soared then crashed during the pandemic

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
INO

Motley Fool

a year ago

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript

INO

Associated Press Finance

a year ago

Inovio: Q3 Earnings Snapshot

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

a year ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
INO

PR Newswire

a year ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

INOVIO to Present at Upcoming Scientific Conferences
INO

PR Newswire

a year ago

INOVIO to Present at Upcoming Scientific Conferences

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
INO

PR Newswire

a year ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
INO

PR Newswire

a year ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Exelixis (EXEL) Soars 8.6%: Is Further Upside Left in the Stock?
INO

Zacks

a year ago

Exelixis (EXEL) Soars 8.6%: Is Further Upside Left in the Stock?

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
INO

Zacks

a year ago

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

INO

MT Newswires

a year ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $7 From $8, Keeps Sector Perform, Speculative Risk

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO to Present at Upcoming Scientific Conferences
INO

PR Newswire

a year ago

INOVIO to Present at Upcoming Scientific Conferences

INOVIO to Present at Upcoming Scientific Conference
INO

PR Newswire

a year ago

INOVIO to Present at Upcoming Scientific Conference

We Think Inovio Pharmaceuticals (NASDAQ:INO) Needs To Drive Business Growth Carefully
INO

Simply Wall St.

a year ago

We Think Inovio Pharmaceuticals (NASDAQ:INO) Needs To Drive Business Growth Carefully

INO

MT Newswires

a year ago

RBC Cuts Price Target on Inovio Pharmaceuticals to $8 From $11, Keeps Sector Perform, Speculative Risk

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript
INO

Motley Fool

a year ago

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript

INO

Associated Press Finance

a year ago

Inovio: Q2 Earnings Snapshot

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

a year ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grant Under Inducement Plan

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107
INO

PR Newswire

a year ago

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
INO

PR Newswire

a year ago

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
INO

Zacks

a year ago

Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?
INO

Zacks

a year ago

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway
INO

PR Newswire

a year ago

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO

MT Newswires

a year ago

Inovio Pharmaceuticals Names Steven Egge Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
INO

PR Newswire

a year ago

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Added to Russell 2000® Index Effective July 1, 2024
INO

PR Newswire

a year ago

INOVIO Added to Russell 2000® Index Effective July 1, 2024

Lotto 6/49 - $64 million up for grabs in the next draw!
INO

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
INO

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
INO

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
INO

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
INO

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
INO

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
INO

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
INO

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
INO

PR Newswire

a year ago

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grants Under Inducement Plan

Better Buy: Inovio Pharmaceuticals vs. Novavax
INO

Motley Fool

a year ago

Better Buy: Inovio Pharmaceuticals vs. Novavax

INO

MT Newswires

a year ago

Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target

INO

GuruFocus.com

a year ago

Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
INO

Motley Fool

a year ago

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO

Associated Press Finance

a year ago

Inovio: Q1 Earnings Snapshot

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INO

PR Newswire

a year ago

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
INO

Motley Fool

a year ago

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?

INOVIO Reports Inducement Grants Under Inducement Plan
INO

PR Newswire

a year ago

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
INO

PR Newswire

a year ago

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

INOVIO to Participate in Upcoming Investor Conferences in May
INO

PR Newswire

a year ago

INOVIO to Participate in Upcoming Investor Conferences in May

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
INO

PR Newswire

a year ago

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
INO

PR Newswire

2 years ago

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
INO

Zacks

2 years ago

Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
INO

Insider Monkey

2 years ago

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript

INO

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Inovio Pharmaceuticals Inc Earnings Call

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
INO

Motley Fool

2 years ago

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
INO

PR Newswire

2 years ago

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
INO

PR Newswire

2 years ago

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
INO

Zacks

2 years ago

Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
INO

PR Newswire

2 years ago

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
INO

Zacks

2 years ago

Inovio (INO) Moves 17.4% Higher: Will This Strength Last?

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
INO

PR Newswire

2 years ago

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

INOVIO Reports Inducement Grant Under Inducement Plan
INO

PR Newswire

2 years ago

INOVIO Reports Inducement Grant Under Inducement Plan

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
INO

Zacks

2 years ago

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

PlayAGS (AGS) Surges 8.7%: Is This an Indication of Further Gains?
INO

Zacks

2 years ago

PlayAGS (AGS) Surges 8.7%: Is This an Indication of Further Gains?

Share on Social Networks: